Japan’s Eisai aims to roll out its groundbreaking Alzheimer’s drug Leqembi to 1,500 people in China later this year, but expects
Japan’s Eisai aims to roll out its groundbreaking Alzheimer’s drug Leqembi to 1,500 people in China later this year, but expects
Japan’s Eisai aims to roll out its groundbreaking Alzheimer’s drug Leqembi to 1,500 people in China later this year, but expects
Japan’s Eisai aims to roll out its groundbreaking Alzheimer’s drug Leqembi to 1,500 people in China later this year, but expects
Japan’s Eisai aims to roll out its groundbreaking Alzheimer’s drug Leqembi to 1,500 people in China later this year, but expects
Japan’s Eisai aims to roll out its groundbreaking Alzheimer’s drug Leqembi to 1,500 people in China later this year, but expects
A crucial party election Friday will determine Japan's new prime minister
Moncler CEO strengthens grip on company with LVMH deal
Costco says doing 'a little bit of everything' to prepare for US port strike
Japan’s next prime minister could be its first woman leader
Migrant crossings through Panama's Darien Gap down 35% in 2024
Column-China's FX conundrum mutes stimulus optimism: McGeever
Core inflation in Japan's capital matches BOJ target
Ex-'Apprentice' candidates dump nearly entire stake in owner of Trump's Truth Social platform
Attorneys tweak $2.78B college settlement, remove the word 'booster' from NIL language
7 Mountain West schools agree to stay, steadying the conference amid realignment
Sean ‘Diddy’ Combs wants to testify at his trial, lawyer says: ‘I don’t know that I can keep him off the stand’